Statements of Stockholders' Equity (Deficit) (Parenthetical) - USD ($)	12 Months Ended
Dec. 31, 2018	Dec. 31, 2017
Offering costs	$ 2,123,106
Biocon
Sale of stock, price per share		$ 0.005

The cash outflow for cost incurred directly with the issuance of an equity security.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585

Name:	us-gaap_PaymentsOfStockIssuanceCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration